Actively Recruiting

Phase 3
Age: 10Years - 17Years
All Genders
NCT06372964

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

Led by Intra-Cellular Therapies, Inc. · Updated on 2025-07-08

384

Participants Needed

59

Research Sites

154 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients who are experiencing major depressive episodes (MDEs) associated with a primary diagnosis of bipolar I or bipolar II disorder as confirmed by Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL), according to criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM 5).

CONDITIONS

Official Title

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

Who Can Participate

Age: 10Years - 17Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Written informed consent by legally authorized representative and written assent by patient
  • Male or female patients aged 10 to 17 years inclusive
  • Primary diagnosis of bipolar I or bipolar II disorder with current major depressive episode confirmed by clinical interview
  • Lifetime history of at least one manic or hypomanic episode
  • Current major depressive episode duration between 4 weeks and less than 12 months
  • Children's Depression Rating Scale-Revised (CDRS-R) total score of 45 or higher with a score of 5 or higher on depressed feelings item at screening and baseline
  • Young Mania Rating Scale (YMRS) score of 15 or less, with a score of 2 or less on elevated mood item at screening and baseline
Not Eligible

You will not qualify if you...

  • Primary psychiatric diagnosis other than bipolar I or bipolar II disorder (except ADHD with stable treatment for at least 30 days prior to screening expected to remain stable)
  • Intellectual disability based on clinical judgment and DSM-5 criteria
  • Hospitalization for bipolar manic episode within 30 days before randomization
  • Improvement of 25% or more in CDRS-R total score between screening and baseline or CDRS-R score below 45 at baseline
  • Significant risk of suicidal behavior as determined by investigator, including recent suicidal ideation or attempts, high suicidal ideation scores on rating scales, or considered imminent danger to self or others

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 59 locations

1

Clinical Site

Dothan, Alabama, United States, 36303

Actively Recruiting

2

Clinical Site

Little Rock, Arkansas, United States, 72204

Actively Recruiting

3

Clinical Site

Anaheim, California, United States, 92805

Actively Recruiting

4

Clinical Site

Redlands, California, United States, 92373

Actively Recruiting

5

Clinical Site

Sacramento, California, United States, 95817

Not Yet Recruiting

6

Clinical Site

San Diego, California, United States, 92103

Actively Recruiting

7

Clinical Site

West Covina, California, United States, 91790

Actively Recruiting

8

Clinical Site

Colorado Springs, Colorado, United States, 80910

Actively Recruiting

9

Clinical Site

Gainesville, Florida, United States, 32607

Not Yet Recruiting

10

Clinical Site

Hialeah, Florida, United States, 33012

Actively Recruiting

11

Clinical Site

Homestead, Florida, United States, 33030

Actively Recruiting

12

Clinical Site

Miami, Florida, United States, 33122

Actively Recruiting

13

Clinical Site

Miami, Florida, United States, 33125

Actively Recruiting

14

Clinical Site

Miami, Florida, United States, 33130

Actively Recruiting

15

Clinical Site

Miami, Florida, United States, 33134

Actively Recruiting

16

Clinical Site

Miami, Florida, United States, 33144

Actively Recruiting

17

Clinical Site

Miami, Florida, United States, 33165

Actively Recruiting

18

Clinical Site

Miami, Florida, United States, 33173

Actively Recruiting

19

Clinical Site

Miami, Florida, United States, 33176

Actively Recruiting

20

Clinical Site

Miami, Florida, United States, 33186

Actively Recruiting

21

Clinical Site

Miami Gardens, Florida, United States, 33056

Actively Recruiting

22

Clinical Site

Miami Lakes, Florida, United States, 33014

Actively Recruiting

23

Clinical Site

Miami Lakes, Florida, United States, 33016

Actively Recruiting

24

Clinical Site

Miami Springs, Florida, United States, 33166

Actively Recruiting

25

Clinical Site

Orlando, Florida, United States, 32803

Actively Recruiting

26

Clinical Site

West Palm Beach, Florida, United States, 33407

Actively Recruiting

27

Clinical Site

Atlanta, Georgia, United States, 30318

Actively Recruiting

28

Clinical Site

Decatur, Georgia, United States, 30030

Actively Recruiting

29

Clinical Site

Lawrenceville, Georgia, United States, 30046

Actively Recruiting

30

Clinical Site

Savannah, Georgia, United States, 31405

Actively Recruiting

31

Clinical Site

Chicago, Illinois, United States, 60611

Not Yet Recruiting

32

Clinical Site

Indianapolis, Indiana, United States, 46202

Actively Recruiting

33

Clinical Site

Baltimore, Maryland, United States, 21229

Not Yet Recruiting

34

Clinical Site

Bloomfield Hills, Michigan, United States, 48302

Actively Recruiting

35

Clinical Site

Saint Charles, Missouri, United States, 63304

Actively Recruiting

36

Clinical Site

Lincoln, Nebraska, United States, 68526

Actively Recruiting

37

Clinical Site

Kinston, North Carolina, United States, 28504

Not Yet Recruiting

38

Clinical Site

Avon Lake, Ohio, United States, 44012

Actively Recruiting

39

Clinical Site

Cincinnati, Ohio, United States, 45219

Actively Recruiting

40

Clinical Site

Garfield, Ohio, United States, 44125

Actively Recruiting

41

Clinical Site

Westlake, Ohio, United States, 44145

Actively Recruiting

42

Clinical Site

Oklahoma City, Oklahoma, United States, 73112

Actively Recruiting

43

Clinical Site

Oklahoma City, Oklahoma, United States, 73116

Actively Recruiting

44

Clinical Site

Austin, Texas, United States, 78759

Actively Recruiting

45

Clinical Site

Flower Mound, Texas, United States, 76028

Actively Recruiting

46

Clinical Site

Frisco, Texas, United States, 75034

Not Yet Recruiting

47

Clinical Site

Houston, Texas, United States, 77089

Actively Recruiting

48

Clinical Site

Houston, Texas, United States, 77090

Actively Recruiting

49

Clinical Site

Richmond, Texas, United States, 77407

Actively Recruiting

50

Clinical Site

Richmond, Virginia, United States, 23220

Actively Recruiting

51

Clinical Site

Bellevue, Washington, United States, 98007

Actively Recruiting

52

Clinical Site

Everett, Washington, United States, 98201

Actively Recruiting

53

Clinical Site

Ahmedabad, India, 380008

Actively Recruiting

54

Clinical Site

Aurangabad, India, 431005

Actively Recruiting

55

Clinical Site

Nashik, India, 422005

Actively Recruiting

56

Clinical Site

Varanasi, India, 221005

Actively Recruiting

57

Clinical Site

Belgrade, Serbia, 11000

Actively Recruiting

58

Clinical Site

Niš, Serbia, 18000

Actively Recruiting

59

Clinical Site

Novi Sad, Serbia, 21000

Actively Recruiting

Loading map...

Research Team

I

ITI Clinical Trials

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here